Coronary inflammation: Insights from the fat attenuation index
Dr Kenneth ChanWatch the presentation >
Candidate genes that reduce VLDL secretion without inducing fatty liver
Professor Antoine RimbertWatch the presentation >
Inhibition of apoC3 or ANGPTL3 for reduction of ASCVD?
Professor Erik SG StroesWatch the presentation >
Silencing ANGPTL3 or apoC3 with siRNAs in mixed dyslipidaemia: The ARCHES-2 and MUIR trials
Dr Robert Sidney RosensonWatch the presentation >
Targeting apoC3 with olezarsen to lower triglyceride-rich lipoproteins in moderate hypertriglyceridaemia: The BRIDGE trial
Dr Brian BergmarkWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
